Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Your why may not be what you think it is. by Jonathan Knowles, Tom Hunsaker, Hannah Grove and Alison James Today’s business leaders are under pressure to come up with a corporate purpose, much as they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results